Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Atherosclerosis. 2007 Dec 3;199(1):110–115. doi: 10.1016/j.atherosclerosis.2007.10.010

Table 2.

Association (Spearman rank correlation and p-value) of Lp-PLA2 activity with different continuous parameters across various sex/race strata.

White Men (n = 480) White Women (n = 518) Hispanic men (n = 236) Hispanic women (n = 334) Black Men (n = 743) Black Women (n = 1,021)
Age 0.07, P=0.10 −0.07, P=0.12 0.05, P=0.41 0.11, P−0.04 0.09, P=0.02 −0.01, P=0.73
BMI 0.00, P=1 0.03, P=0.47 0.06, P=0.36 0.03, P=0.55 0.13, P<0.001 −0.01, P=0.84
Total cholesterol 0.37, P<0.001 0.24, P<0.001 0.33, P<0.001 0.30, P<0.001 0.32, P<0.001 0.32, P<0.001
LDL 0.48, p<0.001 0.43, P<0.001 0.45, P<0.001 0.38, P<0.001 0.46, P<0.001 0.45, P<0.001
HDL −0.22, P<0.001 −0.38, P<0.001 −0.12, P=0.06 −0.23, P<0.001 −0.31, P<0.001 −0.28, P<0.001
Triglycerides 0.08, P=0.10 0.14, P=0.002 0.02, P=0.75 0.11, P=0.04 0.11, P=0.003 0.09, P=0.003
hsCRP 0.06, P=0.17 −0.14, P=0.002 0.04, P=0.57 −0.12, P=0.04 0.06, P=0.08 −0.09, P=0.03

BMI, body mass index; LDL, low density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; CRP, C-reactive protein; Lp-PLA2, lipoprotein-associated phospholipase A2